Physician profile
Daniel Barba
NPI 1407128580
$1,482,323.01
in general payments reported to CMS, 2019-2025
19 companies · $307K in 2025
The $307K reported for 2025 was more than what 97% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136K · 2020: $128K · 2021: $188K · 2022: $217K · 2023: $231K · 2024: $273K · 2025: $307K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $537K · Consulting Fee: $269K · Food and Beverage: $5,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $537,087.67 |
| Consulting Fee | $269,379.14 |
| Food and Beverage | $5,859.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurora Spine, INC. | $613,447.23 | 2019-2025 | Zip, Aurora Spine |
| Globus Medical, INC. | $466,888.31 | 2019-2025 | Hedron Ia, Hedron, Excelsiusgps Robotic Navigation System |
| Orthofix Medical, INC. | $229,044.01 | 2023-2025 | Meridian, Physio-Stim, Waveform C |
| Seaspine Orthopedics Corporation | $97,318.00 | 2019-2022 | |
| Djo, LLC | $25,760.80 | 2021-2025 | Procare, Cmf, Aircast |
| Spineart Sa | $17,656.00 | 2021-2024 | |
| Spineart USA INC | $15,747.58 | 2019-2022 | |
| Nuvasive, INC. | $8,844.93 | 2019 | |
| The Institute of Musculoskeletal Science and Education | $4,625.00 | 2020-2021 | |
| Camber Spine Technologies LLC | $1,505.59 | 2019-2022 | |
| Kci USA, INC. | $1,000.00 | 2019 | |
| Surgalign Spine Technologies, INC. | $115.25 | 2020 | |
| Depuy Synthes Sales INC. | $102.12 | 2019 | |
| Baxter Healthcare | $93.38 | 2020-2024 | Floseal |
| Medtronic, INC. | $85.12 | 2025 | Anteralign Spinal System With Titan Nanolock Surface Technology |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $40.81 | 2025 | Biasurge |
| Abbott Laboratories | $21.53 | 2023 | Octrode |
| Endo Pharmaceuticals INC. | $14.14 | 2019 | |
| Assertio Therapeutics, INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Barba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.